David Braun, MD, PhD, Assistant Professor of Medicine (Medical Oncology) and the Louis Goodman and Alfred Gilman Yale Scholar, has been awarded a American Society for Clinical Investigation (ASCI) Young Physician-Scientist Award.
Dr. Braun is among 40 early-career awardees to be selected for noteworthy achievements in their field, and has been invited to attend the AAP/ASCI/APSA Joint Meeting, April 20-23. He is a member of the Center of Molecular and Cellular Oncology at Yale Cancer Center and cares for patients with kidney cancers. He has a longstanding interest in integrating experimental and computational approaches to biomedical research and is currently studying mechanisms of response and resistance to immune therapy in kidney cancer, with the goal of developing novel therapies. He received his PhD in Computational Biology from the Courant Institute of Mathematical Science at New York University and his medical degree from Icahn School of Medicine at Mount Sinai. He completed his residency at the Brigham and Women’s Hospital where he received the Dunn Medical Intern Award and served as Chief Medical Resident before completing fellowship training in adult oncology through the Dana-Farber/Partners CancerCare program where he was appointed the Emil Frei Fellow and the John R. Svenson Fellow.
Established in 1908, the ASCI Council Young Physician-Scientist Awards (YPSA) recognize physician-scientists who are early in their first faculty appointment and have made notable achievements in their research. With these awards, the ASCI seeks to encourage and inspire these physician-scientists through their participation in the Joint Meeting.